Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release

Vincristine is an important component of many regimens used for pediatric and adult malignancies, but it causes a dose-limiting sensorimotor neuropathy for which there is no effective treatment. This study aimed to delineate the neuro-inflammatory mechanisms contributing to the development of mechanical allodynia and gait disturbances in a murine model of vincristine-induced neuropathy, as well as to identify novel treatment approaches. Here, we show that vincristine-induced peripheral neuropathy is driven by activation of the NLRP3 inflammasome and subsequent release of interleukin-1β from macrophages, with mechanical allodynia and gait disturbances significantly reduced in knockout mice lacking NLRP3 signaling pathway components, or after treatment with the NLRP3 inhibitor MCC950. Moreover, treatment with the IL-1 receptor antagonist anakinra prevented the development of vincristine-induced neuropathy without adversely affecting chemotherapy efficacy or tumor progression in patient-derived medulloblastoma xenograph models. These results detail the neuro-inflammatory mechanisms leading to vincristine-induced peripheral neuropathy and suggest that repurposing anakinra may be an effective co-treatment strategy to prevent vincristine-induced peripheral neuropathy.

The integration of sequential aiming movements: Switching hand and direction at the first target

Movement times to a single target are typically shorter compared to when movement to a second target is required. This one target movement time advantage has been shown to emerge when participants use a single hand throughout the target sequence and when there is a switch between hands at the first target. Our goal was to investigate the lacuna in the movement integration literature surrounding the interactive effects between switching hands and changing movement direction at the first target. Participants performed rapid hand movements in five conditions; movements to a single target; two target movements with a single hand in which the second target required an extension or reversal in direction; and movements to two targets where the hands were switched at the first target and the second target required an extension or reversal in direction. The significance of including these latter two (multiple hand-multiple direction) movements meant that for the first time research could differentiate between peripheral and central processes within movement integration strategies. Reaction times were significantly shorter in the single task compared to the two target tasks. More importantly, movement times to the first target were significantly shorter in the single target task compared to all two target tasks (reflecting the so-called one target advantage), except when the second movement was a reversal movement with the same hand. These findings demonstrate for the first time the contrasting effects of movement integration at central and peripheral levels.

Comparison of a simple dose-guided intervention technique for prostate radiotherapy with existing anatomical image guidance methods

OBJECTIVES

A simple dose-guided intervention technique for prostate radiotherapy using an isodose overlay method combined with soft-tissue-based corrective couch shifts has been proposed previously. This planning study assesses the potential clinical impact of such a correction strategy.

METHODS

10 patients, each with 8-11 on-treatment CT studies (n=97), were assessed using this technique and compared with no intervention, bony anatomy intervention and soft-tissue intervention methods. Each assessment technique used a 4-mm action level for intervention. Outcomes were evaluated using measures of sensitivity, specificity and dosimetric effect, and compared across intervention techniques. Dosimetric effect was defined as the change in dosimetric coverage by the 95% isodose from the no intervention case of an evaluation construct called the verification target volume.

RESULTS

Bony anatomy, soft tissue and dosimetric overlay-based interventions demonstrated sensitivity of 0.56, 0.73 and 1.00 and specificity of 0.64, 0.20 and 0.66, respectively. A detrimental dosimetric effect was shown in 7% of interventions for each technique, with benefit in 30%, 35% and 55% for bony anatomy, soft tissue and dosimetric overlay techniques, respectively.

CONCLUSION

Used in conjunction with soft-tissue-based corrective couch shifts, the dosimetric overlay technique allows effective filtering out of dosimetrically unnecessary interventions, making it more likely that any intervention made will result in improved target volume coverage.

Craniospinal irradiation using a forward planned segmented field technique

Craniospinal irradiation is technically demanding due to the complex shape of the planning target volume (PTV). Radiotherapy treatment techniques have evolved over time as imaging and radiotherapy treatment technology have improved. However, most are variations on a class solution utilizing a prone patient position with two shaped lateral cranial portals and a matched posterior spinal portal with moving junctions. Major areas of difficulty remain with the accurate definition of the PTV and achieving a homogeneous dose within it, especially at the junctions. We describe a three-dimensionally (3D) planned craniospinal radiation technique that permits rapid image acquisition with reduced localization time, simplified spinal PTV definition and standardized cranial PTV definition. Improved dose homogeneity within the PTV is achieved by use of a segmented "field-in-field" technique (forward planned intensity-modulated radiotherapy (IMRT)) in place of customized compensators. This has negated the requirement for constructing physical compensators. Autosequencing for field delivery enables the junction to be "moved" during a single fraction and reduces the overall treatment time, an important consideration when treating very young patients.

Geometric leaf placement strategies

Geometric leaf placement strategies for multileaf collimators (MLCs) typically involve the expansion of the beam's-eye-view contour of a target by a uniform MLC margin, followed by movement of the leaves until some point on each leaf end touches the expanded contour. Film-based dose-distribution measurements have been made to determine appropriate MLC margins--characterized through an index d90--for multileaves set using one particular strategy to straight lines lying at various angles to the direction of leaf travel. Simple trigonometric relationships exist between different geometric leaf placement strategies and are used to generalize the results of the film work into d90 values for several different strategies. Measured d90 values vary both with angle and leaf placement strategy. A model has been derived that explains and describes quite well the observed variations of d90 with angle. The d90 angular variations of the strategies studied differ substantially, and geometric and dosimetric reasoning suggests that the best strategy is the one with the least angular variation. Using this criterion, the best straightforwardly implementable strategy studied is a 'touch circle' approach for which semicircles are imagined to be inscribed within leaf ends, the leaves being moved until the semicircles just touch the expanded target outline.

Validation of treatment planning system data: variation in the modelling of three 6 MV beams for extreme rectangular fields

The validation of photon beam data on the Helax-TMS treatment planning system at the Northern Centre for Cancer Treatment takes the form of profile and depth dose comparisons against measured data for square fields. With a view to using Helax-TMS to plan fixed source-to-surface distance spine fields, validation of extreme rectangular fields was undertaken, based on guidelines published by the American Association of Physicists in Medicine Radiation Therapy Committee (Task Group report 53). The accuracy with which the Helax-TMS-generated profiles matched those measured varied between treatment machines. For three 6 MV beams in the department, two beams showed agreement to within 2% in the central portion of the field, while the third beam demonstrated differences of up to 4.4% in this region. The disparities were attributed to the modelling of the primary dose for each beam by Helax-TMS.

How should the repeatability of clinical measurements be analysed? An assessment of analysis techniques with data from cardiovascular autonomic function tests

A reliable clinical test should give similar results when repeated on the same patient. Repeatability data, however, can be presented in several ways, giving apparently different results. We compared two approaches--the coefficient of variation, and the SD ratio (SD of repeat measurements/SD of subject means). Repeat measurements of two published studies of cardiovascular autonomic function response were analysed. The test measurements were divided into two groups: group A tests, for which no response results in a zero output (includes measurements of differences or changes); and group B tests, for which no response results in a unity or other non-zero output (includes measurements of ratios). Data were obtained from 10 normal and 25 diabetic subjects. There were significant differences between the coefficients of variation of the two groups of tests for the normal subjects (p < 0.01) and for the diabetic subjects (p < 0.01). Low coefficients of variation were more likely to belong to group B (ratio measurements) than to be an estimate of good repeatability. The calculation of the coefficient of variation was adapted to ensure that the test calculation tended to zero with low autonomic function. There was a strong relationship, especially with the diabetic subjects, between repeatability calculated from the adapted coefficient of variation and from the SD ratio (normal subjects, r = 0.63; diabetic subjects, r = 0.91). The calculation of coefficient of variation is often misused, and low coefficients of variation presented in the literature may not represent good repeatability of a clinical test.

Autonomic function testing in diabetic subjects using sequential measurements

The repeatability of commonly used electrocardiographic (ECG) related autonomic function tests was investigated in 25 diabetic subjects, mean age 44 (range 18-67) years and mean duration of diabetes 10 (< 1-35) years. Tests were based on deep breathing, the Valsalva manoeuvre, relaxed normal breathing, and standing up from a lying position. All tests were repeated twice at each session, with two sessions separated by a mean of 5 (range 3-8) months. ECG and respiratory data were recorded for subsequent analysis. Maximum (max) and minimum (min) RR intervals and instantaneous heart rate (HR) were determined. The mean and repeatability data (within-subject standard deviation) for 21 different test results were calculated, and included deep breathing sitting (max-min)RR 226 +/- 39 ms and (max-min)HR 19.3 +/- 3.2 beats min-1, Valsalva manoeuvre 1.74 +/- 0.18, and lying-to-standing RR ratio 1.19 +/- 0.07. The within-subject repeatability to between-subject variability ratios consistently demonstrated that it is better to perform the deep breathing test sitting (with the smaller mean ratio of 0.37) rather than supine (0.46), with the use of three respiratory cycles rather than a single cycle (0.33 compared with 0.50 for (max-min)RR). A significant (p = 0.037) relationship was found between variability in heart rate changes and variability in air volume breathed during the deep breathing test.

Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function

OBJECTIVE

To determine the repeatability and sources of variability of clinical tests of cardiovascular autonomic function.

DESIGN

The commonly used electrocardiographic related tests of autonomic function were studied. Two repeat measurements of all tests were made on all subjects on four separate days over a four week period.

SUBJECTS

Ten normal subjects with no known autonomic dysfunction were investigated.

MAIN OUTCOME MEASURES

These were deep breathing (subject seated and supine), Valsalva manoeuvre, standing up from lying position, and normal relaxed breathing (subject supine). During the tests the electrocardiogram and respiratory pattern were recorded by computer. Beat to beat RR intervals were measured automatically from the electrocardiogram, and from these the results of the tests were calculated.

RESULTS

Variance analysis showed significant between subject variability for all tests (p < 0.005), but some tests showed a much smaller relative within subject variability than others. Average repeatability data (within subject SD) for each test were calculated, and included deep breathing sitting (max-min) RR (46 ms), Valsalva ratio (0.17), and lying to standing RR ratio (0.11). These compare with between subject SDs of 65 ms, 0.38, and 0.13 respectively, at mean values of 305 ms, 1.92, and 1.15 respectively. The data highlighted one subject with the poorest repeatability, whose electrocardiogram turned out on closer inspection to be under atrial rather than sinus control at times. Poor repeatability in the other subjects was related to variability in the respiratory pattern, and in the deep breathing test, repeat variability was significantly correlated (r = 0.79) with variability in the respiratory amplitude (p < 0.05).

CONCLUSIONS

Repeatability data should be available to each laboratory carrying out autonomic function tests. The data provided in this study could be used as a baseline. Poor repeatability highlights the need to re-examine the test procedures, or the test data from specific subjects. Variability of respiratory pattern is associated with poor repeatability, and so careful instructions on respiration should be given to each subject before the tests.

Repeatability of dynamic eye pupil response measurement using the Pupilscan instrument

The repeatability of pupil response measurements made with the Pupilscan instrument has been assessed. Two operators made 32 repeat recordings of the pupil response in each eye of eight normal subjects over four days. A total of 512 recordings were made and the results analysed by variance analysis. Room light levels were carefully controlled. The instrument measured initial pupil diameter, and after a 0.2 s light stimulus measured minimum and final diameters, maximum diameter change, constriction velocity and time to minimum diameter. For all measurements except time to minimum, there were significant differences (P less than 0.001) between the normal subjects. Day-to-day variation was also significant (P less than 0.005), but did not mask the differences between subjects. It is concluded that the average of at least four repeat measurements are made, giving error ranges similar to those observed from day-to-day changes.

Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine

1. Fifty patients with symptoms due to chronic heart failure despite diuretic therapy were randomised to receive additional treatment with either hydralazine or captopril. The dose was titrated; 24 received hydralazine and 26 captopril up to a maximum daily dosage of 225 mg and 75 mg respectively. Forty-three patients had coronary heart disease and seven dilated cardiomyopathy. 2. Dyspnoea and tiredness were assessed using a visual analogue scale (0-100) before and during 12 weeks' treatment. Captopril produced a significantly greater reduction in breathlessness (F = 31.6, P less than 0.001) and tiredness (F = 65.8, P less than 0.001) compared with hydralazine. 3. There was an increase in treadmill exercise time during treatment with both hydralazine (from 5.5 (3.47-7.53) min to 6.9 (4.87-8.93) min), and captopril (from 5.0 (3.05-6.95) min to 7.8 (5.85-9.75) min), but the degree of improvement was significantly greater in the patients treated with captopril (F = 7.4, P less than 0.001). 4. There was no significant change in right ventricular ejection fraction (from 27.9 (19.3-36.5)% to 28.7 (20.1-37.3)%) or left ventricular ejection fraction (from 22.2 (14.2-30.2)% to 23.9 (15.9-31.9)%) during treatment with hydralazine. However, both right and left ventricular ejection fraction increased significantly during treatment with captopril (from 27.1 (18.9-35.3)% to 32.0 (23.8-40.2)%, P less than 0.05; and from 25.0 (17.2-32.8)% to 29.6 (21.8-37.4)%, P less than 0.05 respectively). 5. These results suggest that in patients with symptoms due to chronic heart failure despite diuretic therapy, treatment with captopril produces a greater symptomatic and haemodynamic improvement than treatment with hydralazine.

Evaluation of myocardial thallium tomography in patients with chest pain

Thirty-seven patients with chest pain have been studied by exercise thallium tomography and coronary arteriography to assess the accuracy of thallium tomography in the identification of patients with coronary artery disease and to evaluate whether knowledge of clinical data improves this accuracy. Thallium tomography was also used to identify which coronary arteries were stenosed. Thallium tomography when compared with coronary arteriography has a sensitivity of 97%, a specificity of 75%, and an overall accuracy of 92% for the detection of coronary artery disease. When clinical information was made available, these results improved to a sensitivity of 100%, a specificity of 75%, and an overall accuracy of 95%. In the identification of which coronary arteries were stenosed, thallium tomography had a sensitivity of 85%, a specificity of 89%, and an overall accuracy of 86%. These results show that exercise thallium tomography can be an accurate non-invasive screening test in patients with chest pain thought to be angina.